Citigroup’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-49,800
Closed -$376K 6157
2021
Q1
$376K Buy
+49,800
New +$562K ﹤0.01% 3648

Other funds holding CLOV

Citigroup's CLOV Position: Q1 2026 in Review

Citigroup increased its Clover Health Investments (CLOV) stake by 131% in Q1 2026, buying an estimated $44.3K and bringing the position to 36,084 shares worth $63.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4433.

Citigroup first reported a position in CLOV in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.02M in Q4 2021. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Citigroup held 36,084 shares of Clover Health Investments worth $63.5K as of Q1 2026.
  • Citigroup bought 20,438 Clover Health Investments shares in Q1 2026, an estimated $44.3K.
  • Clover Health Investments made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4433 holding.
  • Citigroup first reported a position in Clover Health Investments in Q4 2020 and has held it in 22 quarters since.
  • Citigroup's Clover Health Investments position peaked at $3.02M in Q4 2021.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.